Advertisement

MediWound Ltd. MDWD

Set alert

Price alert · MDWD

All alert types
13.30 USD -0.56 -4.04%

At close · Oct 30

13.30 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
13.30 × 2
Ask
13.35 × 2
13.24 Day range 13.94
11.80 52-week range 19.70
YTD
-27.95%
1 year
-28.30%
Open
13.94
Prev close
13.86
Mkt cap
171.71M
Vol
110.11K
Avg vol
94.57K
EPS
-2.17
P/E
0.00
Div yield
0.00%
More statistics
Low
13.24
High
13.94
Forward P/E
-7.96
Beta
0.84
Short ratio
18.59
Inst. own
45.50%
Dividend
0.00
Ex-div date
50-d avg
17.27
200-d avg
17.21
1y target
29.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 26, 2024Earnings: -0.98; estimate -0.48; surprise -104.17%
  • Nov 27, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (123)
NameDateAgo
SMA: BullishOct 28, 20264 days ago
MACD: Buy SignalOct 27, 20265 days ago
RSI: OversoldOct 14, 20262 weeks ago
MACD: Sell SignalOct 6, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 24, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
MACD: Buy SignalSep 3, 20261 month ago
RSI: OversoldAug 26, 20262 months ago
SMA: BearishAug 10, 20262 months ago
MACD: Sell SignalAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
MACD: Sell SignalJul 30, 20263 months ago
MACD: Buy SignalJul 27, 20263 months ago
MACD: Sell SignalJul 24, 20263 months ago
MACD: Buy SignalJul 16, 20263 months ago
MACD: Sell SignalJul 15, 20263 months ago
MACD: Buy SignalJun 16, 20264 months ago
RSI: OversoldJun 1, 20265 months ago
MACD: Sell SignalMay 27, 20265 months ago
RSI: OversoldMay 27, 20265 months ago
SMA: BearishMay 22, 20265 months ago
SMA: BullishMay 20, 20265 months ago
MACD: Buy SignalMay 20, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
SMA: BearishMay 8, 20265 months ago
MACD: Buy SignalMay 5, 20266 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Sell SignalApr 23, 20266 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BearishApr 16, 20266 months ago
SMA: BullishApr 8, 20266 months ago
MACD: Buy SignalApr 6, 20266 months ago
RSI: OversoldMar 27, 20267 months ago
MACD: Sell SignalMar 11, 20267 months ago
MACD: Buy SignalMar 10, 20267 months ago
MACD: Sell SignalMar 6, 20268 months ago
MACD: Buy SignalMar 4, 20268 months ago
MACD: Sell SignalMar 3, 20268 months ago
SMA: BearishFeb 24, 20268 months ago
SMA: BullishFeb 23, 20268 months ago
MACD: Buy SignalFeb 20, 20268 months ago
MACD: Sell SignalFeb 11, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BullishJan 30, 20269 months ago
SMA: BearishJan 29, 20269 months ago
SMA: BullishJan 28, 20269 months ago
MACD: Buy SignalJan 27, 20269 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BearishJan 12, 20269 months ago
MACD: Sell SignalJan 12, 20269 months ago
MACD: Buy SignalJan 7, 20269 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BearishJan 2, 202610 months ago
SMA: BullishDec 31, 202510 months ago
SMA: BullishDec 31, 202510 months ago
SMA: BearishDec 30, 202510 months ago
SMA: BearishDec 30, 202510 months ago
MACD: Sell SignalDec 29, 202510 months ago
SMA: BullishDec 8, 202510 months ago
SMA: BullishDec 8, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
SMA: BearishNov 26, 202511 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 19, 202511 months ago
SMA: BearishNov 18, 202511 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BearishNov 14, 202511 months ago
SMA: BullishNov 13, 202511 months ago
SMA: BearishNov 12, 202511 months ago
SMA: BullishNov 11, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishNov 7, 202511 months ago
SMA: BearishOct 31, 20251 year ago
SMA: BullishOct 30, 20251 year ago
SMA: BearishOct 27, 20251 year ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BullishOct 14, 20251 year ago
SMA: BullishOct 9, 20251 year ago
SMA: BearishSep 12, 20251 year ago
SMA: BearishSep 12, 20251 year ago
SMA: BullishSep 11, 20251 year ago
SMA: BullishSep 10, 20251 year ago
MACD: Buy SignalSep 10, 20251 year ago
RSI: OversoldSep 5, 20251 year ago
RSI: OversoldAug 28, 20251 year ago
RSI: OversoldAug 26, 20251 year ago
RSI: OversoldAug 19, 20251 year ago
MACD: Sell SignalJul 29, 20251 year ago
SMA: BearishJul 25, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 21, 20251 year ago
SMA: BullishJul 18, 20251 year ago
SMA: BearishJul 16, 20251 year ago
SMA: BullishJul 9, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
SMA: BearishJun 26, 20251 year ago
SMA: BullishJun 24, 20251 year ago
SMA: BearishJun 20, 20251 year ago
MACD: Sell SignalJun 6, 20251 year ago
RSI: OverboughtMay 30, 20251 year ago
RSI: OverboughtMay 16, 20251 year ago
RSI: OverboughtMay 13, 20251 year ago
MACD: Buy SignalMay 12, 20251 year ago
MACD: Sell SignalMay 9, 20251 year ago
SMA: BullishApr 17, 20251 year ago
MACD: Buy SignalApr 11, 20251 year ago
MACD: Sell SignalMar 24, 20251 year ago
SMA: BearishMar 20, 20251 year ago
SMA: BullishMar 13, 20251 year ago
MACD: Buy SignalMar 12, 20251 year ago
SMA: BearishFeb 21, 20251 year ago
SMA: BullishFeb 13, 20251 year ago
SMA: BearishFeb 10, 20251 year ago
MACD: Sell SignalFeb 7, 20251 year ago
MACD: Buy SignalJan 14, 20251 year ago
MACD: Sell SignalJan 7, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago

Key statistics

Market cap
190.66M
Enterprise value
138.07M
Trailing P/E
0.00
Forward P/E
-7.96
PEG ratio
0.00
Price / sales
9.47
Price / book
5.16
EPS (TTM)
-2.91
Beta
0.84
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-99.17%
Revenue (TTM)
20.14M
Revenue growth
6.10%
Free cash flow
-8.42M
Total cash
29.21M
Total debt
6.36M
Return on equity
-75.66%
Shares outstanding
10.79M
Short % of float
6.43%
50-day average
17.27
200-day average
17.21

Analyst view

Consensus: none

Price target (mean) 29.00 +118.0% upside
Target (low)
25.00
Target (mean)
29.00
Target (high)
36.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.55667.

Earnings history

Financials — quick view

All financials
MDWD Revenue — quarterly 3.09M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MDWD Net income — quarterly -7.39M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
MDWD EPS — quarterly -0.57
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

MDWD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 26, 2024Sep 1, 2024-0.48-0.98-0.50-104.17%
Aug 14, 2024Jun 1, 2024-0.42-0.68-0.26-61.90%
May 29, 2024Mar 1, 2024-0.40-0.39+0.01+2.50%
Mar 21, 2024Dec 1, 2023-0.23-0.19+0.04+17.39%
Nov 21, 2023Sep 1, 2023-0.45-0.24+0.21+46.67%
Aug 15, 2023Jun 1, 2023-0.410.10+0.51+124.39%

Upgrades / downgrades

MDWD analyst upgrades and downgrades
DateFirmActionFromTo
Nov 27, 2024HC Wainwright & Co.mainBuyBuy
Oct 11, 2024HC Wainwright & Co.reitBuyBuy
Aug 15, 2024HC Wainwright & Co.reitBuyBuy
Jul 16, 2024HC Wainwright & Co.reitBuyBuy
May 30, 2024HC Wainwright & Co.reitBuyBuy
Mar 22, 2024HC Wainwright & Co.reitBuyBuy

About MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel

News

Your note

Sign in to keep a note on MDWD — it syncs with the Stock Master app.

Institution ownership

MDWD institution ownership
Holder% heldSharesValueReported
Investor AB6.83%872,09315.41MSep 29, 2024
Yelin Lapidot Holdings Management Ltd.5.88%750,74313.27MSep 29, 2024
Rosalind Advisors, Inc.4.92%628,05011.10MSep 29, 2024
Blackrock Inc.3.39%432,9967.65MSep 29, 2024
Balyasny Asset Management LLC1.30%165,7362.93MSep 29, 2024
Sargent Investment Group, LLC0.92%117,1922.07MSep 29, 2024

Fund ownership

MDWD fund ownership
Holder% heldSharesValueReported
iShares Russell 2000 ETF1.62%206,3803.65MOct 30, 2024
ARK ETF Tr-ARK Israel Innovative Technology ETF0.91%115,7652.05MOct 30, 2024
Fidelity Small Cap Index Fund0.64%81,7441.44MAug 30, 2024
iShares Russell 2000 Growth ETF0.55%70,1501.24MOct 30, 2024
Vanguard Russell 2000 Index Fund0.25%32,376572.08KAug 30, 2024
1290 Fds-1290 Essex Small Cap Growth Fd0.17%21,233375.19KJul 30, 2024
Advertisement